Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lavigne

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2001
Formation of cyclopentadienyl and ruthenacyclopentadienyl derivatives through ynenyl-diyne and ynenyl-alkyne couplings onto a triruthenium cluster coreJ A Cabeza, I del Río, S García-Granda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 6, 2016
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014Y Dargaud, A Pavlova, S Lacroix-Desmazes, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2015
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trialG Lavigne-Lissalde, A G Aya, F J Mercier, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2001
Formation of cyclopentadienyl and ruthenacyclopentadienyl derivatives through ynenyl-diyne and ynenyl-alkyne couplings onto a triruthenium cluster coreJ A Cabeza, I del Río, S García-Granda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 6, 2016
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014Y Dargaud, A Pavlova, S Lacroix-Desmazes, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2015
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trialG Lavigne-Lissalde, A G Aya, F J Mercier, et al.
Pageof 8